Are you Dr. Gillespie-Twardy?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 77 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2013 Jefferson St SW
Fl 2
Roanoke, VA 24014Phone+1 540-982-0237Fax+1 540-982-2719
Summary
- Dr. Amanda Gillespie-Twardy, MD is an oncologist in Roanoke, Virginia. She is currently licensed to practice medicine in Virginia and Pennsylvania. She is affiliated with Carilion Roanoke Memorial Hospital and LewisGale Medical Center.
Education & Training
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2011 - 2014- UPMC Medical EducationResidency, Internal Medicine, 2007 - 2010
Virginia Commonwealth University School of MedicineClass of 2007
Certifications & Licensure
VA State Medical License 2014 - 2026
PA State Medical License 2007 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 124 citationsZanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.Jennifer R Brown, Barbara Eichhorst, Peter Hillmen, Wojciech Jurczak, Maciej Kaźmierczak
The New England Journal of Medicine. 2023-01-26 - 22 citationsZanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial.Peter Hillmen, Barbara Eichhorst, Jennifer R Brown, Nicole Lamanna, Susan M O'Brien
Journal of Clinical Oncology. 2023-02-10 - Sustained Benefit of Zanubrutinib vs Ibrutinib in Patients With R/R CLL/SLL: Final Comparative Analysis of ALPINE.Jennifer R Brown, Barbara Eichhorst, Nicole Lamanna, Susan M O'Brien M.D, Constantine S Tam
Blood. 2024-09-24
